Latest news with #PlaneCrash
Business Upturn
4 days ago
- Business
- Business Upturn
Fortis shares surge over 3% as Q1 revenue jumps 16.5% YoY to Rs 2,166 crore, net profit up 57% YoY
By Aman Shukla Published on August 7, 2025, 09:16 IST Shares of Fortis Healthcare Ltd rallied over 3% in early trade on Thursday after the company reported a strong set of numbers for the quarter ended June 30, 2025 (Q1 FY26). As of 9:16 AM, the shares 2.59% higher at Rs 880.35. The hospital chain posted a net profit of ₹260 crore, up 56.6% from ₹166 crore in the same quarter last year. The company's revenue from operations rose 16.5% year-on-year to ₹2,166 crore, compared to ₹1,859 crore in the corresponding period of the previous fiscal. The growth was supported by robust performance across its hospital and diagnostics businesses. On the operational front, EBITDA (earnings before interest, tax, depreciation and amortisation) stood at ₹490.4 crore, a jump of 43% over ₹343 crore in Q1 FY25. The EBITDA margin improved significantly to 22.6%, from 18.4% in the year-ago period, reflecting enhanced operational efficiencies and better cost management. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
4 days ago
- Business
- Business Upturn
Lucas Digne puts a full-stop to rumours; Agrees to sign a new deal with Villa
Lucas Digne has decided to sign a new deal at Aston Villa this summer. By Ravi Kumar Jha Published on August 7, 2025, 08:41 IST Lucas Digne has decided to sign a new deal at Aston Villa this summer. The player wants to stay at the club and fight for the top titles. The deal has been agreed between the parties until June 2028. This means the extension is of 3 years and Digne is ready to commit his future to the club. There were several clubs who were approaching Villa for the left-back, but Digne puts a full-stop to all the rumours. Aston Villa left-back Lucas Digne has officially agreed to sign a new contract with the club, extending his stay until June 2028. The French international, who joined Villa in January 2022, has put an end to recent transfer speculation by pledging his long-term future to Unai Emery's side. Despite interest from several clubs across Europe, Digne has made it clear that he wants to remain at Villa Park and help the club compete for top honours. The new deal adds three more years to his existing contract, reflecting his desire to stay and fight for silverware. Digne has been a key figure in Villa's recent success under Emery, bringing experience, consistency, and quality down the left flank. His decision to extend his contract is a major boost for the team as they prepare for a busy campaign in the Premier League and European competitions. Ahmedabad Plane Crash Ravi kumar jha is an undergraduate student in Bachelor of Arts in Multimedia and Mass Communication. A media enthusiast who has a strong hold on communication and he also has a genuine interest in sports. Ravi is currently working as a journalist at
Business Upturn
6 days ago
- Business
- Business Upturn
KP Energy Q1 Results: Revenue surges 73% YoY to Rs 219.47 crore, net profit up 40% YoY
KP Energy has posted a strong set of numbers for the first quarter of FY26, registering its best-ever Q1 performance across multiple financial metrics. The company reported a consolidated total income of ₹220.60 crore, marking a solid 63% growth compared to ₹135.21 crore in the same quarter last year. Revenue from operations stood at ₹219.47 crore, up 73% from ₹127.18 crore last year, showcasing sustained operational strength and project execution momentum. EBITDA rose to ₹49.62 crore, showing a 63% increase over last year, while profit before tax stood at ₹34.75 crore, reflecting a 50% jump. Net profit also hit a new Q1 record at ₹25.42 crore, up from ₹18.21 crore a year ago. Basic EPS improved from ₹2.73 to ₹3.81, a growth of 39%. Looking ahead, KP Energy is well-positioned for expansion with a pipeline of over 2GW in multi-year orders and in-principle approval for 100MW ISTS connectivity, opening up opportunities for interstate power sales. The company is also exploring offshore wind ventures in Gujarat and Tamil Nadu and strengthening its grid capabilities through STU and CTU networks. Enhanced site quality assessments, advanced wind turbine technology, and predictive AI-based O&M practices continue to support operational efficiency and scalability. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
28-07-2025
- Entertainment
- Business Upturn
Is ‘Heartstopper' returning for season 4? Everything we know so far
By Aman Shukla Published on July 28, 2025, 19:30 IST Last updated July 28, 2025, 12:18 IST If you're like most Heartstopper fans, you've probably been wondering: What's next for Charlie and Nick? Season 3, which landed in October 2024, tugged at all the right heartstrings—full of growth, tough conversations, and love that felt real. But ever since those final credits rolled, one big question's been floating around: Are we getting a Season 4? Well, we finally have our answer. And it's a bit of a curveball. No Season 4—But a Heartstopper Movie Is Coming On April 22, 2025—marking three years since the show first premiered—Netflix officially announced that Season 3 was the final season. But don't worry, that's not the end of the road. Instead of another batch of episodes, Heartstopper will return one last time as a feature-length film. Yep, a full-on movie finale. The film will adapt Volume 6 of Alice Oseman's Heartstopper graphic novels (the final volume) along with moments from the beloved Nick and Charlie novella. According to Oseman, this movie is meant to be a 'magical conclusion' to the story—and one that fans truly deserve. She's deeply involved, just like always, and says she's excited to wrap things up in a way that does justice to Charlie and Nick's journey. Why a Movie Instead of Season 4? Honestly, it makes sense when you hear Oseman talk about it. After back-to-back seasons and a pretty intense schedule, she admitted it's been exhausting juggling writing and production. Volume 6 of the graphic novel is still being created—she only picked it back up in late 2024 after a break. So, instead of stretching out the final arc over another full season, a movie gives her space to focus on the heart of the story without the burnout . Plus, narratively, the show has followed the books closely: Season 1 = Volumes 1 & 2 Season 2 = Volume 3 Season 3 = Volumes 4 & 5 With only Volume 6 left, a single movie feels like the natural finale. It also allows for a more cinematic look at what's next for Nick and Charlie—things like university, growing up, and navigating long-distance love. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
28-07-2025
- Business
- Business Upturn
Senores Pharma's subsidiary Havix completes USFDA inspection with 3 observations
Senores Pharmaceuticals announced that its material subsidiary, Havix Group Inc. (doing business as Aavis Pharmaceuticals), successfully completed a routine inspection by the U.S. Food and Drug Administration (USFDA). The inspection was conducted at Havix's manufacturing facility located at 9488 Jackson Trail Road, Hoschton, Georgia, USA, from July 21 to July 25, 2025. The USFDA issued three Form 483 observations following the inspection. According to the company, all the observations are procedural and minor in nature. Havix is committed to addressing the points raised and will submit its response to the USFDA within the stipulated 15-day period. In the exchnge filings, the company shared, 'We hereby inform that Havix Group Inc. D/B/A Aavis Pharmaceuticals ('Havix'), a Material Subsidiary of the Company situated at 9488 Jackson Trail Road, Hoschton, Georgia 30548, USA has completed the United States Food & Drug Administration ('USFDA') inspection of its manufacturing facility from July 21, 2025 to July 25, 2025 with 3 (Three), 483 observations.' This development reaffirms Senores Pharma's ongoing commitment to maintaining global quality standards at its facilities. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
